Elsevier

Cellular Immunology

Volume 122, Issue 2, September 1989, Pages 534-547
Cellular Immunology

Clonotypic heterogeneity of lewis rat T cells specific for the encephalitogenic 68–86 region of myelin basic protein

https://doi.org/10.1016/0008-8749(89)90099-3Get rights and content

Abstract

Experimental autoimmune encephalomyelitis was induced in a Lewis rat by sensitization with synthetic peptide GP68-86, representing the 68–86 sequence of guinea pig myelin basic protein (GPMBP). To delineate T cell determinants of GP68-86, lymph node cells from this rat were activated in culture with GP68-86 and were fused with cells of the mouse thymoma BW5147. The resultant hybrids were cloned by limiting dilution and screened for GP68-86-evoked secretion of IL 2 in the presence of rat splenocytes. Twelve T cell hybrids derived in this manner were tested for reactivity to different heterologous species of MBP as well as to substituted or truncated analogs of GP68-86. The hybrids generally exhibited potent reactivity to GPMBP but differed markedly in their reactivity to autologous rat MBP (RMBP). A few exceptional hybrids exhibited crossreactivity with peptides in which native serine75 or serine80 residues of GPMBP were substituted with either alanine75 (A75) or proline80 (P80) residues. These cross-reactive hybrids also possessed high levels of anti-RMBP reactivity. The remaining hybrids were unresponsive to the A75 and P80 substituted peptides and, with one exception, had relatively low levels of anti-RMBP reactivity. Unique reactivity patterns were also revealed by hybrid responses to peptides having modified C-terminal 84–86 residues. In summary, the contrasting fine specificities of different hybrids indicated that several distinct clones of T cells mediate the immune response of Lewis rats against the 68–86 region of GPMBP. Furthermore, heterogeneity in the hybrid response to “self” RMBP may reflect substantial differences in encephalitogenic potency of the T cell clones from which these hybrids were derived.

References (16)

  • E.H. Eylar et al.

    J. Biol. Chem

    (1971)
  • R.F. Kibler et al.

    J. Exp. Med

    (1977)
  • C.-H.J. Chou et al.

    J. Neurochem

    (1977)
  • C.-H.J. Chou et al.

    J. Immunol

    (1979)
  • A. Ben-Nun et al.

    J. Immunol

    (1982)
  • A.A. Vandenbark et al.

    J. Immunol

    (1985)
  • M.D. Mannie et al.
  • M.W. Kies
There are more references available in the full text version of this article.

Cited by (21)

View all citing articles on Scopus

This investigation was supported by NIH Grants AI-19273 and NS 06262, by a Postdoctoral Fellowship from the National Multiple Sclerosis Society (Grant FG 758-A-1), and by The Mulvihill Family Foundation in Memory of Rosemary Mulvihill Speth.

2

Dr. Mark D. Mannie is a Postdoctoral Fellow of the National Multiple Sclerosis Society.

3

Dr. Philip Y. Paterson is a Javits Neuroscience Investigator.

View full text